overview

The 11^thAnnual Pharma Regulatory Affairs Asia is the leading platform for regulatory experts, to be updated with latest country updates and strategies to navigate the complex and ever changing regulations in the region. With a 10-year track record, IBC Asia brings to market the latest developments and key insights from decision makers.

Part of the 5^th Annual PharmaCon Asia, meet and network with industry leaders and implementers, and get up-to-speed on the latest insights and case studies in pharma across 4 co-located events.

“The event was beneficial in understanding new therapy areas and challenges which are beyond generic pharmaceuticals.”

– Rakesh Chaurasia, Advisor, Strategic International Regulatory Affairs, PT Dexa Medica

Snapshot of 2018 Attendee List:

View »

Conference Highlights

• Updates on the regulatory harmonization efforts in Asia for pharmaceutical drugs
• Country-specific regulatory updates on the latest guidelines and initiatives
• Global eCTD transition and acceleration in emerging markets and China
• Use of AI in pharmaceutical regulatory operations
• Enhancing launch excellence and cross-functional connections for better regulatory outcomes
• Post-marketing surveillance requirements – best practices for compliance in managing post-approval changes, clinical research, safety
• Global and regional outlook on drug e-labelling initiatives

Part of

Pharmacon Asia >>

Co-Located Events

Accelerating Clinical Trials in Asia >>
Pharma Regulatory Affairs Asia >>
Pharma Market Access and Pricing Summit Asia >>
Digital Pharma Summit >>